• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于基层医疗诊所筛查潜在类风湿性关节炎的经济高效机器学习模型的开发与验证

Development and Validation of a Cost-Effective Machine Learning Model for Screening Potential Rheumatoid Arthritis in Primary Healthcare Clinics.

作者信息

Wu Wenqi, Hu Xiaohao, Yan Linyang, Li Zhiyin, Li Bo, Chen Xinpeng, Lin Zexun, Zeng Huiqiong, Li Chun, Mo Yingqian, Wu Yalin, Wang Qingwen

机构信息

Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.

Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen, People's Republic of China.

出版信息

J Inflamm Res. 2025 Feb 3;18:1511-1522. doi: 10.2147/JIR.S487595. eCollection 2025.

DOI:10.2147/JIR.S487595
PMID:39925929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11804240/
Abstract

OBJECTIVE

In primary healthcare, diagnosing rheumatoid arthritis (RA) is challenging due to a general lack of in-depth knowledge of RA by general practitioners (GPs) and the lack of effective tools, leading to high rates of missed diagnosis. This study focuses on a screening model for primary healthcare, aiming to improve early RA screening accuracy and efficiency at a relatively lower cost, reducing delays in GPs' recognition of RA.

METHODS

We randomly selected 2106 participants from the RA group or combined control group (comprising healthy individuals and patients with non-RA rheumatic diseases) at Peking University Shenzhen Hospital as the developing cohort. Guided by experienced rheumatologists, we built a comprehensive database with 26 clinical features. Using 10 classical machine learning algorithms, we developed screening models. Evaluation metrics determined the best model. Employing multivariatelogistic regression results and the best-performing model to identify the least costly features, ensuring applicability in primary healthcare clinics. Subsequently, we retrained and validated our proposed model based on two primary healthcare validation cohorts.

RESULTS

In experiments, the algorithms achieved over 88% accuracy on training and test sets. Random Forest (RF) excelled with 96.20% (95% CI 95.39% to 97.02%) accuracy, 96.22% (95% CI 95.40% to 97.03%) specificity, 96.18% (95% CI 95.37% to 97.00%) sensitivity, and 96.20% (95% CI 95.39% to 97.02%) Areas Under Curves (AUC). A meticulous feature selection identified 11 key features for RA screening. In an external test on two primary healthcare datasets with these features, RF demonstrated an accuracy of 88.435% (95% CI 85.55% to 91.32%), sensitivity of 98.55% (95% CI 97.47% to 99.63%), specificity of 85.56% (95% CI 82.39% to 88.73%), and an AUC of 92.055% (95% CI 89.62% to 94.49%).

CONCLUSION

The screening model excels in automating prompt identification of RA in primary healthcare, improving the early detection of RA, and reducing delays and associated costs. Our findings contribute positively and are poised to elevate prospective RA management, fostering improvements in healthcare sector responsiveness and resource efficiency.

摘要

目的

在基层医疗保健中,由于全科医生(GP)对类风湿性关节炎(RA)普遍缺乏深入了解且缺乏有效工具,导致RA的诊断具有挑战性,漏诊率很高。本研究聚焦于基层医疗保健的筛查模型,旨在以相对较低的成本提高RA早期筛查的准确性和效率,减少全科医生对RA识别的延迟。

方法

我们从北京大学深圳医院的RA组或联合对照组(包括健康个体和非RA风湿性疾病患者)中随机选择2106名参与者作为开发队列。在经验丰富的风湿病学家的指导下,我们建立了一个包含26种临床特征的综合数据库。使用10种经典机器学习算法,我们开发了筛查模型。评估指标确定了最佳模型。利用多变量逻辑回归结果和表现最佳的模型来识别成本最低的特征,以确保在基层医疗诊所的适用性。随后,我们基于两个基层医疗验证队列对我们提出的模型进行了重新训练和验证。

结果

在实验中,这些算法在训练集和测试集上的准确率超过88%。随机森林(RF)表现出色,准确率为96.20%(95%可信区间95.39%至97.02%),特异性为96.22%(95%可信区间95.40%至97.03%),敏感性为96.18%(95%可信区间95.37%至97.00%),曲线下面积(AUC)为96.20%(95%可信区间95.39%至97.02%)。经过细致的特征选择,确定了11个用于RA筛查的关键特征。在对具有这些特征的两个基层医疗数据集进行的外部测试中,RF的准确率为88.435%(95%可信区间85.55%至91.32%),敏感性为98.55%(95%可信区间97.47%至99.63%),特异性为85.56%(95%可信区间82.39%至88.73%),AUC为92.055%(95%可信区间89.62%至94.49%)。

结论

该筛查模型在基层医疗保健中能出色地自动快速识别RA,提高RA的早期检测率,减少延迟和相关成本。我们的研究结果具有积极贡献,并有望提升RA的前瞻性管理,促进医疗保健部门响应能力和资源效率的提高。

相似文献

1
Development and Validation of a Cost-Effective Machine Learning Model for Screening Potential Rheumatoid Arthritis in Primary Healthcare Clinics.一种用于基层医疗诊所筛查潜在类风湿性关节炎的经济高效机器学习模型的开发与验证
J Inflamm Res. 2025 Feb 3;18:1511-1522. doi: 10.2147/JIR.S487595. eCollection 2025.
2
Highly sensitive detection platform-based diagnosis of oesophageal squamous cell carcinoma in China: a multicentre, case-control, diagnostic study.基于高灵敏度检测平台的中国食管鳞状细胞癌诊断:一项多中心、病例对照诊断研究。
Lancet Digit Health. 2024 Oct;6(10):e705-e717. doi: 10.1016/S2589-7500(24)00153-5.
3
Development and validation of a rheumatoid arthritis case definition: a machine learning approach using data from primary care electronic medical records.类风湿关节炎病例定义的制定和验证:基于初级保健电子病历数据的机器学习方法。
BMC Med Inform Decis Mak. 2024 Nov 27;24(1):360. doi: 10.1186/s12911-024-02776-w.
4
Machine learning-based prediction model integrating ultrasound scores and clinical features for the progression to rheumatoid arthritis in patients with undifferentiated arthritis.基于机器学习的预测模型,整合超声评分和临床特征,用于预测未分化关节炎患者进展为类风湿关节炎的情况。
Clin Rheumatol. 2025 Feb;44(2):649-659. doi: 10.1007/s10067-025-07304-3. Epub 2025 Jan 10.
5
A Novel Ensemble-Based Technique for the Preemptive Diagnosis of Rheumatoid Arthritis Disease in the Eastern Province of Saudi Arabia Using Clinical Data.基于集成的新型技术,用于使用临床数据对沙特阿拉伯东部省份的类风湿性关节炎疾病进行早期诊断。
Comput Math Methods Med. 2022 Sep 14;2022:2339546. doi: 10.1155/2022/2339546. eCollection 2022.
6
Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis.基于机器学习的类风湿关节炎和强直性脊柱炎患者生物制剂反应预测模型。
Arthritis Res Ther. 2021 Oct 9;23(1):254. doi: 10.1186/s13075-021-02635-3.
7
Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis.复杂机器学习算法与多变量逻辑回归在类风湿关节炎中预测甲氨蝶呤临床反应不足方面的比较
J Pers Med. 2021 Jan 14;11(1):44. doi: 10.3390/jpm11010044.
8
Development and validation of a machine learning-based predictive model for assessing the 90-day prognostic outcome of patients with spontaneous intracerebral hemorrhage.基于机器学习的预测模型评估自发性脑出血患者 90 天预后结局的开发与验证。
J Transl Med. 2024 Mar 4;22(1):236. doi: 10.1186/s12967-024-04896-3.
9
Patient's access to healthcare and treatment in rheumatoid arthritis: the views of stakeholders in Portugal.患者在类风湿关节炎中的医疗保健和治疗的可及性:葡萄牙利益相关者的观点。
BMC Musculoskelet Disord. 2013 Sep 25;14:279. doi: 10.1186/1471-2474-14-279.
10
Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models.信息论特征选择和机器学习方法在遗传风险预测模型开发中的应用。
Sci Rep. 2021 Dec 2;11(1):23335. doi: 10.1038/s41598-021-00854-x.

引用本文的文献

1
Machine Learning in Primary Health Care: The Research Landscape.初级卫生保健中的机器学习:研究概况
Healthcare (Basel). 2025 Jul 7;13(13):1629. doi: 10.3390/healthcare13131629.
2
Current application, possibilities, and challenges of artificial intelligence in the management of rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis.人工智能在类风湿关节炎、轴性脊柱关节炎和银屑病关节炎管理中的当前应用、可能性及挑战。
Ther Adv Musculoskelet Dis. 2025 Jun 21;17:1759720X251343579. doi: 10.1177/1759720X251343579. eCollection 2025.

本文引用的文献

1
Rheumatoid arthritis and risk of site-specific cancers: Mendelian randomization study in European and East Asian populations.类风湿关节炎与特定部位癌症风险的相关性:欧洲和东亚人群的孟德尔随机化研究。
Arthritis Res Ther. 2022 Dec 13;24(1):270. doi: 10.1186/s13075-022-02970-z.
2
Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism.巨噬细胞乙酰辅酶 A 羧化酶通过控制糖和脂质代谢来调节急性炎症。
Sci Adv. 2022 Nov 25;8(47):eabq1984. doi: 10.1126/sciadv.abq1984. Epub 2022 Nov 23.
3
Global epidemiology of rheumatoid arthritis.
类风湿关节炎的全球流行病学。
Nat Rev Rheumatol. 2022 Oct;18(10):591-602. doi: 10.1038/s41584-022-00827-y. Epub 2022 Sep 6.
4
Artificial Intelligence in Rheumatoid Arthritis: Current Status and Future Perspectives: A State-of-the-Art Review.类风湿关节炎中的人工智能:现状与未来展望:一篇最新综述
Rheumatol Ther. 2022 Oct;9(5):1249-1304. doi: 10.1007/s40744-022-00475-4. Epub 2022 Jul 18.
5
Serum Uric Acid as a Diagnostic Biomarker for Rheumatoid Arthritis-Associated Interstitial Lung Disease.血清尿酸作为类风湿关节炎相关间质性肺病的诊断生物标志物。
Inflammation. 2022 Aug;45(4):1800-1814. doi: 10.1007/s10753-022-01661-w. Epub 2022 Mar 22.
6
[The standardized diagnosis and treatment of rheumatoid arthritis].[类风湿关节炎的标准化诊断与治疗]
Zhonghua Nei Ke Za Zhi. 2022 Jan 1;61(1):51-59. doi: 10.3760/cma.j.cn112138-20210616-00426.
7
A 9 mRNAs-based diagnostic signature for rheumatoid arthritis by integrating bioinformatic analysis and machine-learning.基于 9 个 mRNA 的生物信息学分析和机器学习相结合的类风湿关节炎诊断标志。
J Orthop Surg Res. 2021 Jan 11;16(1):44. doi: 10.1186/s13018-020-02180-w.
8
Design of a Flexible Wearable Smart sEMG Recorder Integrated Gradient Boosting Decision Tree Based Hand Gesture Recognition.基于梯度提升决策树的柔性可穿戴智能表面肌电信号记录器的设计及其手势识别
IEEE Trans Biomed Circuits Syst. 2019 Dec;13(6):1563-1574. doi: 10.1109/TBCAS.2019.2953998. Epub 2019 Nov 18.
9
Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017.全球、地区和国家类风湿关节炎负担 1990-2017 年:2017 年全球疾病负担研究的系统分析。
Ann Rheum Dis. 2019 Nov;78(11):1463-1471. doi: 10.1136/annrheumdis-2019-215920. Epub 2019 Sep 11.
10
Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?荟萃分析:与抗 CCP 和类风湿因子相比,抗 MCV 能否成为类风湿关节炎分类标准中的下一个生物标志物?
Clin Chem Lab Med. 2019 Oct 25;57(11):1668-1679. doi: 10.1515/cclm-2019-0167.